Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients

doi:10.3748/wjg.v26.i34.5130

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8266)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

530

WORD

192

HTML

4408

Figures (1-5)

328

Tables (1-4)

230

Sum=5688

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

649

Download

1929

Sum=2578

Sep 14, 2020 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 14, 2020; 26(34): 5130-5145
Published online Sep 14, 2020. doi: 10.3748/wjg.v26.i34.5130

Full Size Figure Download Figure

Figure 2 Golgi protein 73 values distribution in different stages of chronic liver diseases. (a) non-cirrhotic patients, 8.4 (4.6) units vs compensated cirrhotic patients, 18.7 (15.3) units vs decompensated cirrhotic or patients with hepatocellular carcinoma (HCC), 29.5 (27.6) units; P < 0.001; and (b) cirrhotic (compensated and decompensated), 22.8 (22.9) units vs HCC patients, 25 (33.7) units; P = 0.07 (Tukey box-and-whisker plots; y-axis is presented in log scale). GP73: Golgi protein 73; HCC: Hepatocellular carcinoma.

Citation: Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, Albesa R, Norman GL, Papp M, Dalekos GN. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol 2020; 26(34): 5130-5145
URL: https://www.wjgnet.com/1007-9327/full/v26/i34/5130.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i34.5130